Research Frontiers (REFR) Liabilities and Shareholders Equity (2010 - 2026)

Research Frontiers has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $3.1 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $3.1 million, down 18.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.3 million (down 20.53% YoY), and the FY2025 annual result was $2.3 million, down 44.26% from the prior year.
• Liabilities and Shareholders Equity came in at $3.1 million for Q1 2026 at Research Frontiers, up from $2.3 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $6.0 million in Q3 2022 to a low of $2.3 million in Q4 2025.
• The 5-year median for Liabilities and Shareholders Equity is $3.8 million (2025), against an average of $3.8 million.
• Across the five-year window, Liabilities and Shareholders Equity surged 55.43% in 2023 and sank 44.26% in 2025, its largest moves.
• Research Frontiers' Liabilities and Shareholders Equity stood at $5.4 million in 2022, then fell by 28.25% to $3.9 million in 2023, then increased by 4.91% to $4.0 million in 2024, then tumbled by 44.26% to $2.3 million in 2025, then soared by 36.81% to $3.1 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $3.1 million (Q1 2026), $2.3 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.